• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组组织型纤溶酶原激活剂溶栓治疗醒后卒中患者的临床疗效及影像学评估:一项随机对照试验

Clinical efficacy and imaging evaluation of recombinant tissue plasminogen activator thrombolytic therapy in patients with wake up stroke: A randomized controlled trial.

作者信息

Zhang Chun-Yang, Yang Bin, Li Dong-Mei, Shi Qiu-Yan, Li Hong, Li Yan-Ling, Wang Cui-Lan

出版信息

Medicine (Baltimore). 2020 Sep 4;99(36):e21958. doi: 10.1097/MD.0000000000021958.

DOI:10.1097/MD.0000000000021958
PMID:32899031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7478595/
Abstract

INTRODUCTION

Wake up stroke starts in sleep and is a more common form of ischemic stroke. At present, it is still controversial whether wake up stroke can be treated with thrombolytic therapy. Therefore, this study will combine imaging techniques to assess the onset time of wake up stroke patients, and to analyze the imaging characteristics of wake up stroke patients and patients suitable for thrombolytic therapy within the time window.

METHODS/DESIGN: This study will be a single-blinded, randomized controlled trial with 2 parallel groups. It will be conducted at North China University of science and technology affiliated hospital.

DISCUSSION

There is no consistent conclusion about the pathogenesis of wake up stroke. Wake up stroke is more likely to manifest as small vessel disease. The incidence of wake up stroke patients is relatively high, and the effectiveness and safety of intravenous thrombolysis under the guidance of multimode imaging therapy in wake up stroke need to be further explored by prospective, large-scale studies.

TRIAL REGISTRATION

ClinicalTrials.gov, ChiCTR2000034402, Registered on 05 July 2020.

摘要

引言

醒后卒中始于睡眠,是缺血性卒中的一种较常见形式。目前,醒后卒中是否可用溶栓治疗仍存在争议。因此,本研究将结合影像学技术评估醒后卒中患者的发病时间,并分析醒后卒中患者及在时间窗内适合溶栓治疗患者的影像学特征。

方法/设计:本研究将是一项单盲、随机对照试验,分为2个平行组。研究将在华北理工大学附属医院进行。

讨论

关于醒后卒中的发病机制尚无一致结论。醒后卒中更易表现为小血管病。醒后卒中患者的发病率相对较高,多模态影像指导下静脉溶栓治疗醒后卒中的有效性和安全性有待前瞻性、大规模研究进一步探索。

试验注册

ClinicalTrials.gov,ChiCTR2000034402,于2020年7月5日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0286/7478595/708eb4c48d22/medi-99-e21958-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0286/7478595/4355582a8a03/medi-99-e21958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0286/7478595/708eb4c48d22/medi-99-e21958-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0286/7478595/4355582a8a03/medi-99-e21958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0286/7478595/708eb4c48d22/medi-99-e21958-g003.jpg

相似文献

1
Clinical efficacy and imaging evaluation of recombinant tissue plasminogen activator thrombolytic therapy in patients with wake up stroke: A randomized controlled trial.重组组织型纤溶酶原激活剂溶栓治疗醒后卒中患者的临床疗效及影像学评估:一项随机对照试验
Medicine (Baltimore). 2020 Sep 4;99(36):e21958. doi: 10.1097/MD.0000000000021958.
2
Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.快速 MRI 指导下的清醒型缺血性卒中的重组组织型纤溶酶原激活剂研究。
Cerebrovasc Dis. 2019;48(1-2):85-90. doi: 10.1159/000503379. Epub 2019 Oct 4.
3
A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).一项多中心、随机、双盲、安慰剂对照试验,旨在测试基于磁共振成像的溶栓治疗在醒后卒中(WAKE-UP)中的疗效和安全性。
Int J Stroke. 2014 Aug;9(6):829-36. doi: 10.1111/ijs.12011. Epub 2013 Mar 12.
4
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).一项多中心、随机、双盲、安慰剂对照的 III 期研究,旨在调查在紧急神经功能缺损时延长溶栓时间(EXTEND)。
Int J Stroke. 2012 Jan;7(1):74-80. doi: 10.1111/j.1747-4949.2011.00730.x.
5
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
6
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.阿替普酶 0.6mg/kg 溶栓治疗不明起病时间脑卒中的随机对照研究。
Stroke. 2020 May;51(5):1530-1538. doi: 10.1161/STROKEAHA.119.028127. Epub 2020 Apr 6.
7
Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.WAKE-UP 试验中腔隙性梗死患者静脉溶栓的功能结局。
JAMA Neurol. 2019 Jun 1;76(6):641-649. doi: 10.1001/jamaneurol.2019.0351.
8
Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.症状出现后 3 小时内发生的唤醒性卒中:与标准重组组织型纤溶酶原激活剂治疗的卒中的影像学和临床特征比较。
J Stroke Cerebrovasc Dis. 2013 Aug;22(6):703-8. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.003. Epub 2011 Nov 30.
9
Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST).用于觉醒型缺血性卒中试验(TWIST)的随机对照试验替奈普酶的统计分析计划。
Trials. 2022 May 19;23(1):421. doi: 10.1186/s13063-022-06301-0.
10
Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).静脉溶栓在中国对隐源性卒中安全有效:来自中国急性缺血性卒中溶栓实施与监测(TIMS-China)的数据。
J Stroke Cerebrovasc Dis. 2019 Jan;28(1):220-226. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.041. Epub 2018 Oct 23.

引用本文的文献

1
Clinical risk factors to predict prognosis in wake-up stroke patients: A retrospective study.在觉醒型脑卒中患者中预测预后的临床危险因素:一项回顾性研究。
Medicine (Baltimore). 2024 Nov 15;103(46):e40584. doi: 10.1097/MD.0000000000040584.

本文引用的文献

1
Wake-up stroke and CT perfusion: effectiveness and safety of reperfusion therapy.觉醒型卒中与 CT 灌注:再灌注治疗的有效性与安全性。
Neurol Sci. 2018 Oct;39(10):1705-1712. doi: 10.1007/s10072-018-3486-z. Epub 2018 Jul 10.
2
Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms.阿替普酶静脉溶栓治疗 4.5 小时内觉醒后卒中患者的安全性。
PLoS One. 2018 May 22;13(5):e0197714. doi: 10.1371/journal.pone.0197714. eCollection 2018.
3
Observational Study of Obstructive Sleep Apnea in Wake-Up Stroke: The SLEEP TIGHT Study.
觉醒期卒中患者阻塞性睡眠呼吸暂停的观察性研究:SLEEP TIGHT研究
Cerebrovasc Dis. 2016;41(5-6):233-41. doi: 10.1159/000440736. Epub 2016 Jan 27.
4
Unclear-onset stroke: Daytime-unwitnessed stroke vs. wake-up stroke.不明原因脑卒中:日间无目击者脑卒中与觉醒性脑卒中。
Int J Stroke. 2016 Feb;11(2):212-20. doi: 10.1177/1747493015616513.
5
Wake-up Stroke and Stroke within the Therapeutic Window for Thrombolysis Have Similar Clinical Severity, Imaging Characteristics, and Outcome.觉醒期卒中与溶栓治疗窗内的卒中具有相似的临床严重程度、影像学特征及预后。
J Stroke Cerebrovasc Dis. 2016 Mar;25(3):511-4. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.032. Epub 2015 Nov 27.
6
Computed tomography perfusion-based thrombolysis in wake-up stroke.基于计算机断层扫描灌注成像的醒后卒中溶栓治疗
Intern Emerg Med. 2015 Dec;10(8):977-84. doi: 10.1007/s11739-015-1299-0. Epub 2015 Sep 14.
7
Differences in wake-up and unknown onset stroke examined in a stroke registry.在卒中登记处研究觉醒型和不明原因卒中的差异。
Int J Stroke. 2015 Apr;10(3):331-5. doi: 10.1111/ijs.12388. Epub 2014 Oct 22.
8
Characteristics of wake-up stroke.苏醒期卒中的特征。
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1296-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.021. Epub 2013 Dec 19.
9
Wake-up stroke: incidence, risk factors and outcome of acute stroke during sleep in a Japanese population. Takashima Stroke Registry 1988-2003.觉醒型卒中:日本人群中睡眠期间急性卒中的发生率、危险因素和转归。高知卒中登记研究 1988-2003 年。
Eur Neurol. 2013;69(6):354-9. doi: 10.1159/000346124. Epub 2013 Apr 25.
10
Presentation and outcomes of "wake-up strokes" in a large randomized stroke trial: analysis of data from the International Stroke Trial.大型随机卒中试验中“唤醒性卒中”的表现和结局:来自国际卒中试验的数据分析。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e286-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.016. Epub 2012 Aug 29.